Sequential combination of mitomycin C plus bacillus calmette-guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: Final outcome of CUETO 93009, a randomized prospective trial

  1. Solsona, E.
  2. Madero, R.
  3. Chantada, V.
  4. Fernandez, J.M.
  5. Zabala, J.A.
  6. Portillo, J.A.
  7. Alonso, J.M.
  8. Astobieta, A.
  9. Unda, M.
  10. Martinez-Piñeiro, L.
  11. Rabadan, M.
  12. Ojea, A.
  13. Rodriguez-Molina, J.
  14. Beardo, P.
  15. Muntañola, P.
  16. Gomez, M.
  17. Montesinos, M.
  18. Martinez Piñeiro, J.A.
Revue:
European Urology

ISSN: 1873-7560 0302-2838

Année de publication: 2015

Volumen: 67

Número: 3

Pages: 508-516

Type: Article

DOI: 10.1016/J.EURURO.2014.09.026 GOOGLE SCHOLAR

Objectifs de Développement Durable